Verseon Corporation Change of TIDM (9591S)

TIDMVSN

RNS Number : 9591S

Verseon Corporation

15 March 2019

March 15, 2019

Verseon Corporation

("Verseon" or the "Company")

Change of TIDM

FREMONT, Calif.-Verseon, a clinical-stage pharmaceutical company developing disruptive life-science technologies to advance global health, today announces that effective March 18, 2019, the Company's ticker symbol for the London Stock Exchange will change from 'VSN' to 'VERS'. The Company's ISIN and SEDOL will remain unchanged.

About Verseon

Verseon Corporation is developing disruptive life-science technology to advance global health. The clinical-stage company is using its proprietary, computational drug discovery platform to discover new drug candidates that are unlikely to be found using conventional methods. Pairing its computational engines with a comprehensive in-house chemistry and biology workflow, the company has built a growing pipeline of drug programs. Verseon currently has four active drug programs in the areas of anticoagulation, diabetic macular edema, hereditary angioedema, and oncology.

- Ends -

For further information, please contact:

 
 Verseon Corporation                        www.verseon.com 
 Sebastian Wykeham / Tina Schlafly          +1 (510) 225 9000 
 
 Arden Partners (NOMAD and Joint Broker) 
 Ruari McGirr / Ciaran Walsh / Alex          +44 (0) 20 7614 
  Penney                                      5900 
 
 Cantor Fitzgerald Europe (Joint Broker) 
                                            +44 (0) 20 7894 
 Phil Davies                                 7000

For financial and business media enquiries, please contact

 
 Buchanan Communications Ltd (PR Advisers) 
                                              +44 (0) 20 7466 
 Henry Harrison-Topham / Jamie Hooper          5000

For trade and pharma media enquiries, please contact

 
 Vane Percy & Roberts 
                         +44 (0) 1737 821 
 Simon Vane Percy         890

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCSFAEDLFUSEFD

(END) Dow Jones Newswires

March 15, 2019 08:00 ET (12:00 GMT)

Verseon (LSE:VSN)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024